This summer is likely to be an emotional time for many in Ulverston.

An Australian biotech minnow wants to become the first company globally to register an over-the-counter cannabidiol product ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by anti-corruption authorities. | Eisai plans to lay off 121 employees in the U.

" data-display-label="0" data-show-count="1" data-bookmark-label="Save" data-bookmarked-label="Saved" data-loggedin="0" ...

The sale of a multi-billion euro stake in Ferrari NV has set off a chain reaction in European equity markets, sparking a ...

The Agnelli family’s disposal of a €3 billion ($3.14 billion) stake in Ferrari NV has propelled European block sales to the ...

Novartis' dividend yield currently stands at 3.58%, which is significantly higher than that of the healthcare sector. Read ...

Emasan AG, a subsidiary of the Sandoz Family Foundation, has initiated a public offering of approximately 26.5 million shares ...

Emasan AG, the investment arm of the Sandoz family, has sold a significant stake in Swiss pharmaceutical giant Novartis ...

Southeast Asia stands at a pivotal moment in healthcare development. While the region represents 8.5 per cent of the world’s ...